Men have a significantly increased risk of being diagnosed with, and dying from, colorectal cancer (CRC) than women. Men also participate in fecal occult blood test (FOBT) screening at a lower rate than women. This study will determine whether strategies that target men’s attitudes toward screening, and matched to stage of readiness to screen, increase men’s FOBT participation compared to a standard approach. Eligible trial participants will be a national sample of 9,200 men aged 50 to 74 years, living in urban Australia and randomly selected from the Australian electoral roll. Trial participants will be mailed an advance notification letter, followed 2 weeks later by an invitation letter and a free fecal immunochemical test (FIT) kit. T...
Objective: To describe patient participation and clinical performance in a colorectal cancer (CRC) s...
Objective: To describe patient participation and clinical performance in a colorectal cancer (CRC) s...
ISSUE ADDRESSED: The incidence of skin cancer is rising in many populations around the world. In Aus...
OBJECTIVES: A central tenet of organised cancer screening is that all persons in a target population...
Suboptimal participation is commonly observed in colorectal cancer screening programs utilizing feca...
Opt-out strategies have been shown to improve participation in cancer screening; however, there are ...
OBJECTIVE: Participation, an indicator of screening programme acceptance and effectiveness, varies w...
Abstract Objective: To assess the feasibility and evaluate the performance of a relaunched colorect...
Objective To assess the feasibility and evaluate the performance of a relaunched colorectal cancer (...
Background: Although colorectal cancer screening by using a fecal occult blood test (FOBT), flexible...
Background: This is a registered study protocol on a randomized controlled trial (RCT) testing an in...
Objective To assess the feasibility and evaluate the performance of a relaunched colorectal cancer (...
To assess the population coverage and diagnostic yield of offering an immunochemical faecal occult b...
Objective To assess the feasibility and evaluate the performance of a relaunched colorectal cancer (...
© 2007 Royal Society of MedicineObjectives: To determine the impact of novel invitation strategies o...
Objective: To describe patient participation and clinical performance in a colorectal cancer (CRC) s...
Objective: To describe patient participation and clinical performance in a colorectal cancer (CRC) s...
ISSUE ADDRESSED: The incidence of skin cancer is rising in many populations around the world. In Aus...
OBJECTIVES: A central tenet of organised cancer screening is that all persons in a target population...
Suboptimal participation is commonly observed in colorectal cancer screening programs utilizing feca...
Opt-out strategies have been shown to improve participation in cancer screening; however, there are ...
OBJECTIVE: Participation, an indicator of screening programme acceptance and effectiveness, varies w...
Abstract Objective: To assess the feasibility and evaluate the performance of a relaunched colorect...
Objective To assess the feasibility and evaluate the performance of a relaunched colorectal cancer (...
Background: Although colorectal cancer screening by using a fecal occult blood test (FOBT), flexible...
Background: This is a registered study protocol on a randomized controlled trial (RCT) testing an in...
Objective To assess the feasibility and evaluate the performance of a relaunched colorectal cancer (...
To assess the population coverage and diagnostic yield of offering an immunochemical faecal occult b...
Objective To assess the feasibility and evaluate the performance of a relaunched colorectal cancer (...
© 2007 Royal Society of MedicineObjectives: To determine the impact of novel invitation strategies o...
Objective: To describe patient participation and clinical performance in a colorectal cancer (CRC) s...
Objective: To describe patient participation and clinical performance in a colorectal cancer (CRC) s...
ISSUE ADDRESSED: The incidence of skin cancer is rising in many populations around the world. In Aus...